Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy | SpringerLink
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Antithrombotic Therapy in Patients With Valvular Heart Disease
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
Anticoagulation for Mechanical Heart Valves | Arteriosclerosis, Thrombosis, and Vascular Biology
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology
ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison - ScienceDirect
Mechanical heart valve patients switched to DOACs during COVID-19 pandemic to be reviewed 'urgently' - The Pharmaceutical Journal
Learn Eliquis and Artificial Heart Valves Don't Mix
Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
PROACT Xa Trial to Assess Non-Warfarin Anticoagulation After AVR With a Mechanical Valve – Consult QD
Rivaroxaban in patients with mechanical heart valves: A pilot study - Thrombosis Research
Rivaroxaban
Rivaroxaban noninferior to warfarin in patients with AF, bioprosthetic mitral valve: RIVER
ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison | Journal of the American College of Cardiology
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Switching from Eliquis to Xarelto for blood clots
China Wholesale Dealers of Zone Control Valve - Mechanical Valve JM322 series – Blch factory and suppliers | Blch Pneumatic
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM